Ozempic increased substantially in 2020, surpassing Victoza, and continued to make up the largest share in subsequent years, an increase of 182% between 2019 and 2023
[2] [3] Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide works by mimicking the actions of two naturally occurring incretin hormones
Yes, GLP-1s can reduce your appetite, which can be a significant help in losing pounds, but you still need to have some structure in your eating
However, patients should be cautioned that exercise capacity may be temporarily reduced during the initial treatment period, and expectations should be adjusted accordingly
What limits each of these drugs in practice, according to the article
If youre lucky enough to have insurance cover GLP-1 injections, thats amazing